Overview

Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults

Status:
Unknown status

Trial end date:
2018-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the ability of the early initiation of cART or cART in combination with autologous HIV-1 specific cytotoxic T lymphocyte (CTL) infusion to achieve a post-treatment control among treatment-naïve acute HIV-infected adults.

Phase:

Phase 3

Details

Lead Sponsor:

Yongtao Sun, MD, PhD

Collaborators:

Beijing YouAn Hospital
China Medical University, China
First Affiliated Hospital of Guangxi Medical University
Guangxi Medical University
National Center for AIDS/STD Control and Prevention, China CDC
Shandong Province Centers for Disease Control and Prevention
Tang-Du Hospital
Tangdu Hospital, the Fourth Military Medical University
Zhejiang University

Treatments:

Lamivudine
Lopinavir
Ritonavir
Tenofovir
Zidovudine